ExploreWatchlistsPricing
  1. JP-listed companies
  2. 3-D Matrix,Ltd.
  3. Financials
  4. Cash from financing

3-D Matrix,Ltd. (7777)

Market cap
¥54.7B
P/E ratio
59.2x
Three-D Matrix develops and sells medical devices and pharmaceuticals using exclusive MIT-licensed self-assembling peptide technology for surgery, tissue regeneration, and drug delivery.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCash from financing (Million JPY)YoY (%)
Apr 30, 20252,014-2.37%
Apr 30, 20242,063-30.21%
Apr 30, 20232,956-36.63%
Apr 30, 20224,664+34.68%
Apr 30, 20213,463+120.13%
Apr 30, 20201,573-49.00%
Apr 30, 20193,084+105.12%
Apr 30, 20181,504+485.84%
Apr 30, 2017257+4928.82%
Apr 30, 20165-99.89%
Apr 30, 20154,511

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat